Earnings Watch: McCormick & Co. and PSS Medical on Deck

McCormick & Company, Inc. (NYSE:MKC) will unveil its latest earnings on Thursday, January 26, 2012. The average estimate of analysts is for profit of 97 cents per share, a decline of 2% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 98 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 97 cents during the last month. Analysts are projecting profit to rise by 4.9% versus last year to $2.78.

Last quarter, the company beat estimates by 4 cents, coming in at net income of 69 cents a share versus the estimate of profit of 65 cents a share. It marked the fourth straight quarter of beating estimates. Analysts are projecting a rise of 11.3% in revenue from the year-earlier quarter to $1.09 billion.

Competitors to Watch: TreeHouse Foods Inc. (NYSE:THS), Campbell Soup Company (NYSE:CPB), H.J. Heinz Company (NYSE:HNZ), ConAgra Foods, Inc. (NYSE:CAG), Vitamin Spice (VTMS), General Mills, Inc. (NYSE:GIS), Ralcorp Holdings, Inc. (NYSE:RAH), The Hain Celestial Group, Inc. (NASDAQ:HAIN), The J.M. Smucker Company (NYSE:SJM), and Bridgford Foods Corp. (NASDAQ:BRID).

PSS World Medical, Inc. (NASDAQ:PSSI) will unveil its latest earnings on Thursday, January 26, 2012. The average estimate of analysts is for profit of 39 cents per share, a rise of 11.4% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. For the year, analysts are projecting net income of $1.44 per share, a rise of 9.1% from last year.

The company met estimates last quarter after beating the forecasts in the prior two. In the second quarter, the company reported profit of 37 cents per share versus a mean estimate of net income of 37 cents per share. In the first quarter, the company beat estimates by 3 cents. Analysts are projecting a rise of 5.9% in revenue from the year-earlier quarter to $540 million.

Competitors to Watch: Henry Schein, Inc. (NASDAQ:HSIC), Chindex Intl., Inc. (NASDAQ:CHDX), Patterson Companies, Inc. (NASDAQ:PDCO), Owens & Minor, Inc. (NYSE:OMI), Lincare Holdings Inc. (NASDAQ:LNCR), Cardinal Health, Inc. (NYSE:CAH) and AmerisourceBergen Corp. (NYSE:ABC).

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com